<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Sanofi-aventis Company Newsfeed</title>
<link>http://www.advfn.com/nyse/rss.asp?symbol=SNY</link>
<description>Sanofi-aventis Company Newsfeed</description>
<language>en</language>
<pubDate>Tue, 21 May 2013 12:32:10 EDT</pubDate>
<lastBuildDate>Tue, 21 May 2013 12:32:10 EDT</lastBuildDate>
  
  
 <item>
 <title>Regeneron-Sanofi Asthma Drug Shows Promising Early Results</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57669007&amp;headline=regeneron-sanofi-asthma-drug-shows-promising-early-results</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57669007&amp;headline=regeneron-sanofi-asthma-drug-shows-promising-early-results</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Joseph Walker &#60;/pre&#62;
&#60;p&#62; An experimental drug being developed by Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SNY) showed promising results during a small, mid-stage clinical trial in treating a subset of patients with moderate to severe asthma, but some physicians...</description>
 <pubDate>Tue, 21 May 2013 12:32:10 EDT</pubDate>
 </item>

 <item>
 <title>Sanofi Could Exit Toulouse Site in 5 Years</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57631086&amp;headline=sanofi-could-exit-toulouse-site-in-5-years</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57631086&amp;headline=sanofi-could-exit-toulouse-site-in-5-years</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Mimosa Spencer &#60;/pre&#62;
&#60;p&#62; PARIS--Sanofi SA (SAN.FR) will forge ahead with plans to restructure its French research and development operations, but will take five years to transform operations at its Toulouse R&#38;amp;D site into &#34;autonomous structures,&#34; the company said Friday...</description>
 <pubDate>Fri, 17 May 2013 15:35:08 EDT</pubDate>
 </item>

 <item>
 <title>Sanofi Reports Positive Results on Study on Inhibitor in Myelofibrosis</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57616341&amp;headline=sanofi-reports-positive-results-on-study-on-inhibitor-in-myelofibrosis</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57616341&amp;headline=sanofi-reports-positive-results-on-study-on-inhibitor-in-myelofibrosis</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; French pharmaceutical giant Sanofi SA (SAN.FR) Friday announced a pivotal study examining JAK2 inhibitor SAR302503 for myelofibrosis (MF) had positive results. &#60;/p&#62;
&#60;p&#62; MAIN FACTS: &#60;/p&#62;
&#60;p&#62; - The primary endpoint assessed the proportion of patients achieving &#38;gt;35% reduction...</description>
 <pubDate>Fri, 17 May 2013 01:40:28 EDT</pubDate>
 </item>

 <item>
 <title>French Antitrust Authority Fines Sanofi EUR40.6 Million</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57554793&amp;headline=french-antitrust-authority-fines-sanofi-eur40-6-million</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57554793&amp;headline=french-antitrust-authority-fines-sanofi-eur40-6-million</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Nadya Masidlover &#60;/p&#62;
&#60;p&#62; PARIS--France's antitrust authority said Tuesday it has decided to fine French drugs giant Sanofi SA (SAN.FR) 40.6 million euros ($52.8 million) for what it called a &#34;smear campaign&#34; against certain generic drugs. &#60;/p&#62;
&#60;p&#62; In a statement, the authority...</description>
 <pubDate>Tue, 14 May 2013 06:06:15 EDT</pubDate>
 </item>

 <item>
 <title>Medicare Overpaid $529 Million for Anemia Drugs in 2011 - Report</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57518670&amp;headline=medicare-overpaid-529-million-for-anemia-drugs-in-2011-report</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57518670&amp;headline=medicare-overpaid-529-million-for-anemia-drugs-in-2011-report</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Joseph Walker &#60;/pre&#62;
&#60;p&#62; Medicare paid $529 million more than it should have for antianemia drugs used in the treatment of kidney dialysis patients, a new government report finds, putting further pressure on regulators to reduce its payments for drugs manufactured by Amgen...</description>
 <pubDate>Fri, 10 May 2013 11:47:11 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks End Higher After U.S. Data</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57499904&amp;headline=europe-markets-europe-stocks-end-higher-after-u-s-data</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57499904&amp;headline=europe-markets-europe-stocks-end-higher-after-u-s-data</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Sara Sjolin, MarketWatch &#60;/p&#62;
&#60;p&#62; LONDON (MarketWatch) -- German stocks extended their record streak into a third straight day on Thursday, while a pan-European equity index erased losses to end higher after better-than-expected U.S. jobs data. &#60;/p&#62;
&#60;p&#62; The Stoxx Europe 600...</description>
 <pubDate>Thu, 09 May 2013 12:17:51 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks Trim Losses After U.S. Data</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57497800&amp;headline=europe-markets-europe-stocks-trim-losses-after-u-s-data</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57497800&amp;headline=europe-markets-europe-stocks-trim-losses-after-u-s-data</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Sara Sjolin, MarketWatch &#60;/p&#62;
&#60;p&#62; LONDON (MarketWatch) -- German stocks were flirting with extending its record streak into a third straight day on Thursday, while the broader European stock markets trimmed losses after better-than-expected U.S. jobs data. &#60;/p&#62;
&#60;p&#62; The Stoxx...</description>
 <pubDate>Thu, 09 May 2013 10:51:21 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks Slip After Chinese Inflation Data</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57493963&amp;headline=europe-markets-europe-stocks-slip-after-chinese-inflation-data</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57493963&amp;headline=europe-markets-europe-stocks-slip-after-chinese-inflation-data</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Sara Sjolin, MarketWatch &#60;/p&#62;
&#60;p&#62; LONDON (MarketWatch) -- European stock markets retreated Thursday, after higher-than-expected Chinese inflation data stoked fears the Chinese government will withhold more easing measures. &#60;/p&#62;
&#60;p&#62; U.K. stocks were also slightly lower, after...</description>
 <pubDate>Thu, 09 May 2013 08:21:39 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks Slip As ECB Moves Fall Short</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57412301&amp;headline=europe-markets-europe-stocks-slip-as-ecb-moves-fall-short</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57412301&amp;headline=europe-markets-europe-stocks-slip-as-ecb-moves-fall-short</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets stayed choppy on Thursday as some analysts said a rate cut by the European Central Bank wasn't going far enough to help the struggling euro area. On a busy day for corporate earnings, Statoil...</description>
 <pubDate>Thu, 02 May 2013 10:15:44 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks Still Choppy After ECB Rate Cut</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57410096&amp;headline=europe-markets-europe-stocks-still-choppy-after-ecb-rate-cut</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57410096&amp;headline=europe-markets-europe-stocks-still-choppy-after-ecb-rate-cut</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets stayed choppy after a European Central Bank rate cut on Thursday, showing muted reaction to the widely expected move. On a busy day for corporate earnings, Statoil SA and Sanofi SA dropped...</description>
 <pubDate>Thu, 02 May 2013 08:53:51 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks Cautious As ECB Decision Looms</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57405643&amp;headline=europe-markets-europe-stocks-cautious-as-ecb-decision-looms</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57405643&amp;headline=europe-markets-europe-stocks-cautious-as-ecb-decision-looms</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets traded cautiously on Thursday, with nervousness settling in ahead of the European Central Bank meeting. It was also a busy day for corporate earnings, with Statoil SA and Sanofi SA among...</description>
 <pubDate>Thu, 02 May 2013 05:09:15 EDT</pubDate>
 </item>

 <item>
 <title>Sanofi Sees Second-Half Growth</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57403297&amp;headline=sanofi-sees-second-half-growth</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57403297&amp;headline=sanofi-sees-second-half-growth</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; PARIS--French drugs giant Sanofi SA (SNY) Thursday said it expects a return to growth later in the year as the effects of lost of patent protection on key drugs eases and new products come through its pipeline. &#60;/p&#62;
&#60;p&#62; &#34;The Group expects to resume growth in the second half...</description>
 <pubDate>Thu, 02 May 2013 02:50:08 EDT</pubDate>
 </item>

 <item>
 <title>Sanofi Forecasts Second-Half Growth</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57402972&amp;headline=sanofi-forecasts-second-half-growth</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57402972&amp;headline=sanofi-forecasts-second-half-growth</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Mimosa Spencer &#60;/pre&#62;
&#60;p&#62; PARIS--French drugs giant Sanofi SA (SNY) Thursday said it expects a return to growth later in the year as the effects of lost of patent protection on key drugs eases and new products come through its pipeline. &#60;/p&#62;
&#60;p&#62; &#34;The Group expects to resume...</description>
 <pubDate>Thu, 02 May 2013 02:28:34 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks End Lower But Germany's DAX Gains</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57381638&amp;headline=europe-markets-europe-stocks-end-lower-but-germanys-dax-gains</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57381638&amp;headline=europe-markets-europe-stocks-end-lower-but-germanys-dax-gains</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets ended mostly lower on Tuesday following disappointing economic data, while strong gains for Deutsche Bank AG led the German stock index to a higher finish. &#60;/p&#62;
&#60;p&#62; The Stoxx Europe 600...</description>
 <pubDate>Tue, 30 Apr 2013 12:40:05 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Germany A Bright Spot In A Down Europe Market</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57380043&amp;headline=europe-markets-germany-a-bright-spot-in-a-down-europe-market</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57380043&amp;headline=europe-markets-germany-a-bright-spot-in-a-down-europe-market</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- German stocks provided the lone bright spot in European stocks, where markets broadly fell on downbeat Europe and U.S. economic data and as investors stepped back ahead of key central-bank meetings. Deutsche...</description>
 <pubDate>Tue, 30 Apr 2013 11:25:55 EDT</pubDate>
 </item>

 <item>
 <title>EARNINGS FORECAST TABLE: Sanofi 1Q 2013</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57375354&amp;headline=earnings-forecast-table-sanofi-1q-2013</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57375354&amp;headline=earnings-forecast-table-sanofi-1q-2013</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) first-quarter results, based on a poll of five analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are...</description>
 <pubDate>Tue, 30 Apr 2013 08:19:08 EDT</pubDate>
 </item>

 <item>
 <title>Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57364796&amp;headline=regeneron-pharmaceuticals-co-founder-receives-81-55-million</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57364796&amp;headline=regeneron-pharmaceuticals-co-founder-receives-81-55-million</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Joseph Walker &#60;/pre&#62;
&#60;p&#62; Regeneron Pharmaceuticals Inc.'s (REGN) stock price tripled last year, and the compensation of co-founder and Chief Executive Leonard Schleifer nearly did, too. &#60;/p&#62;
&#60;p&#62; Mr. Schleifer made $30.04 million in 2012, according to filings with the Securities...</description>
 <pubDate>Mon, 29 Apr 2013 15:04:16 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Italy Leads European Stock-market Gains</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57363005&amp;headline=europe-markets-italy-leads-european-stock-market-gains</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57363005&amp;headline=europe-markets-italy-leads-european-stock-market-gains</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets notched moderate gains on Monday, while Italian stocks rallied on relief that a new government was sworn in over the weekend. &#60;/p&#62;
&#60;p&#62; The Stoxx Europe 600 index rose 0.5% to end at 297.39...</description>
 <pubDate>Mon, 29 Apr 2013 12:21:27 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Italy Leads Europe Stocks Gains; ECB Optimism</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57361795&amp;headline=europe-markets-italy-leads-europe-stocks-gains-ecb-optimism</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57361795&amp;headline=europe-markets-italy-leads-europe-stocks-gains-ecb-optimism</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets notched some moderate gains on Monday, with Italian stocks rallying on relief that a new government is finally in place. &#60;/p&#62;
&#60;p&#62; Investors looking ahead to potential easing from the European...</description>
 <pubDate>Mon, 29 Apr 2013 11:17:01 EDT</pubDate>
 </item>

 <item>
 <title>EUROPE MARKETS: Europe Stocks Bid Higher, With Italy In The Lead</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57354147&amp;headline=europe-markets-europe-stocks-bid-higher-with-italy-in-the-lead</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=SNY&amp;article=57354147&amp;headline=europe-markets-europe-stocks-bid-higher-with-italy-in-the-lead</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Barbara Kollmeyer, MarketWatch &#60;/p&#62;
&#60;p&#62; MADRID (MarketWatch) -- European stock markets pushed higher in early trading on Monday, with drug stocks and banks providing support, and Italian stocks in the lead as a new government settled in. Earnings news drove Rentokil Initial...</description>
 <pubDate>Mon, 29 Apr 2013 04:54:34 EDT</pubDate>
 </item>

</channel>
</rss>